Chenevix-Trench G - Search Results

1

Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Spurdle AB, Fahey P, Chen X, McGuffog L; kConFab; Easton D, Peock S, Cook M; EMBRACE; Simard J; INHERIT; Rebbeck TR; MAGIC; Antoniou AC, Chenevix-Trench G. Spurdle AB, et al. Breast Cancer Res Treat. 2010 Jul;122(1):281-5. doi: 10.1007/s10549-009-0601-0. Epub 2009 Nov 18. Breast Cancer Res Treat. 2010. PMID: 19921428 Free PMC article.

2

Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset.

Chenevix-Trench G, Young J, Coggan M, Board P. Chenevix-Trench G, et al. Carcinogenesis. 1995 Jul;16(7):1655-7. doi: 10.1093/carcin/16.7.1655. Carcinogenesis. 1995. PMID: 7614702

3

The prevalence of cervical and thoracic congenital skeletal abnormalities in basal cell naevus syndrome; a review of cervical and chest radiographs in 80 patients with BCNS.

Ratcliffe JF, Shanley S, Chenevix-Trench G. Ratcliffe JF, et al. Br J Radiol. 1995 Jun;68(810):596-9. doi: 10.1259/0007-1285-68-810-596. Br J Radiol. 1995. PMID: 7627481

4

Glutathione S-transferase GSTM1 null genotype is not overrepresented in Australian patients with nevoid basal cell carcinoma syndrome or sporadic melanoma.

Shanley SM, Chenevix-Trench G, Palmer J, Hayward N. Shanley SM, et al. Carcinogenesis. 1995 Aug;16(8):2003-4. doi: 10.1093/carcin/16.8.2003. Carcinogenesis. 1995. PMID: 7634433

5

Fine deletion mapping on the long arm of chromosome 9 in sporadic and familial basal cell carcinomas.

Shanley SM, Dawkins H, Wainwright BJ, Wicking C, Heenan P, Eldon M, Searle J, Chenevix-Trench G. Shanley SM, et al. Hum Mol Genet. 1995 Jan;4(1):129-33. doi: 10.1093/hmg/4.1.129. Hum Mol Genet. 1995. PMID: 7711724

6

The diagnostic implication of falcine calcification on plain skull radiographs of patients with basal cell naevus syndrome and the incidence of falcine calcification in their relatives and two control groups.

Ratcliffe JF, Shanley S, Ferguson J, Chenevix-Trench G. Ratcliffe JF, et al. Br J Radiol. 1995 Apr;68(808):361-8. doi: 10.1259/0007-1285-68-808-361. Br J Radiol. 1995. PMID: 7795971

7

Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years.

Spurdle AB, Dite GS, Chen X, Mayne CJ, Southey MC, Batten LE, Chy H, Trute L, McCredie MR, Giles GG, Armes J, Venter DJ, Hopper JL, Chenevix-Trench G. Spurdle AB, et al. J Natl Cancer Inst. 1999 Jun 2;91(11):961-6. doi: 10.1093/jnci/91.11.961. J Natl Cancer Inst. 1999. PMID: 10359549

8

CYP17 promotor polymorphism and ovarian cancer risk.

Spurdle AB, Chen X, Abbazadegan M, Martin N, Khoo SK, Hurst T, Ward B, Webb PM, Chenevix-Trench G. Spurdle AB, et al. Int J Cancer. 2000 May 1;86(3):436-9. doi: 10.1002/(sici)1097-0215(20000501)86:3<436::aid-ijc21>3.0.co;2-a. Int J Cancer. 2000. PMID: 10760835 Free article.

9

The spectrum of patched mutations in a collection of Australian basal cell carcinomas.

Evans T, Boonchai W, Shanley S, Smyth I, Gillies S, Georgas K, Wainwright B, Chenevix-Trench G, Wicking C. Evans T, et al. Hum Mutat. 2000;16(1):43-8. doi: 10.1002/1098-1004(200007)16:1<43::AID-HUMU8>3.0.CO;2-7. Hum Mutat. 2000. PMID: 10874304

10

Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer.

Spurdle AB, Webb PM, Chen X, Martin NG, Giles GG, Hopper JL, Chenevix-Trench G. Spurdle AB, et al. Int J Cancer. 2000 Sep 1;87(5):637-43. Int J Cancer. 2000. PMID: 10925355 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

569 results

Search Page